Yu Li

Ms. Yu Li

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
YLYu Li
Yu Li
KLKevin J. Lane
Kevin J. Lane
Laura CorlinLaura Corlin
Laura Corlin
APAllison Patton
Allison Patton
JDJohn Durant
John Durant
Doug  BruggeDoug Brugge
Doug Brugge
Ultrafine particle (UFP) concentrations are elevated near busy roadways, however, their effects on prevalence of cardiovascular diseases, diabetes, and hypertension are not well understood. To investigate these associations, data on demographics, diseases, medication use, and time of activities were collected by in-home surveys for 704 participants in three pairs of near-highway and urban background neighborhoods in and near Boston (MA, USA). Body mass index (BMI) was measured for a subset of 435 participants. Particle number concentration (PNC, a measure of UFP) was collected by mobile monitoring in each area. Intra-neighborhood spatial-temporal regression models (approximately 20 m resolution) were used to estimate hourly ambient PNC at the residences of participants. We used participant time activity information to adjust annual average residential PNC values and assign individualized time activity adjusted annual average PNC exposures (TAA-PNC). Using multivariate logistic regression models, we found an odds ratio (OR) of 1.35 (95% CI: 0.83, 2.22) of TAA-PNC with stroke and ischemic heart diseases (S/IHD), an OR of 1.14 (95% CI: 0.81, 1.62) with hypertension, and an OR of 0.71 (95% CI: 0.46, 1.10) for diabetes. A subset analysis controlling for BMI produced slightly stronger associations for S/IHD (OR = 1.61, 95% CI: 0.88, 2.92) and hypertension (OR = 1.28, 95% CI: 0.81, 2.02), and no association with diabetes (OR = 1.09, 95% CI = 0.61, 1.96). Further research is needed with larger sample sizes and longitudinal follow-up.

14 June 2025 in American Heart Journal
Verified
Journal Article
Open access
YLYu Li
Yu Li
MSMary Schiff
Mary Schiff
LOLaura J. Olivieri
Laura J. Olivieri
ACAdam B. Christopher
Adam B. Christopher
VMVictor Morell
Victor Morell
JWJ Weigand
J Weigand
The long-term effect of open fenestration in Fontan patients is unclear, leading to wide practice variation of fenestration creation and closure. We evaluated the long-term outcomes of the fenestration using data from the Fontan Outcome Registry using Cardiac Magnetic Resonance Examinations (FORCE) Study. Patients were categorized by fenestration status determined by post-Fontan cardiac magnetic resonance imaging (CMR) as open fenestration, nonfenestrated Fontan, spontaneous closure, and device closure. The primary outcome was the time from the CMR to the earliest event of death, listing or receiving a heart transplant, plastic bronchitis, or protein-losing enteropathy. The association between fenestration status and the outcome measure was evaluated using Cox proportional hazard models, adjusted for patients' clinical and CMR characteristics. The cohort consisted of 2,923 patients with a median age at CMR of 14.3 years. Patients with open fenestration were younger and less likely to have a systemic left ventricle. Nonfenestrated Fontan patients were more likely to have a systemic left ventricle and lower indexed single ventricle end-diastolic volume (SVEDVi). An open fenestration was associated with adverse outcomes adjusted for clinical variables (hazard ratio 1.70, 95% CI [1.09, 2.64], P = .02). The association was no longer significant when adjusted for CMR variables, while every 10 mL/m2 increase in SVEDVi was associated with a 5% increase in the hazard of clinical outcomes (P < .0001). Open fenestration is associated with adverse outcomes when adjusted for clinical characteristics. The association disappeared when additionally adjusting for CMR variables. The current practice of fenestration closure in selected patients leads to comparable outcomes with spontaneous closure and nonfenestrated Fontan.

7 April 2026 in Pediatric Cardiology
Verified
Journal Article
Open access
PDF file
HLHusayn M. Ladha
Husayn M. Ladha
JWJustin C. Wang
Justin C. Wang
YLYu Li
Yu Li
ACAdam B Christopher
Adam B Christopher
JKJacqueline Kreutzer
Jacqueline Kreutzer
TATarek Alsaied
Tarek Alsaied
Atrioventricular valve regurgitation (AVVR) remains a significant complication post-Fontan. This study evaluates the accuracy of 4D flow AVVR quantification in post-Fontan patients by comparing 4D flow to conventional echocardiographic (AVVR Echo ) and CMR assessments. Patients in the multi-institutional FORCE registry with high-quality 4D flow CMR were included. Regurgitant fractions (RFs) were calculated using two 4D-flow based methods: AVVR AVV−Ao (4D) , calculated from atrioventricular valve and aortic flows, and AVVR Jet , which directly measures AVVR jet volume. 4D flow RFs and severity classifications were compared with AVVR Echo and CMR-reported AVVR severity (AVVR Report−Cat ), and examiner-reported RFs (AVVR Report−RF ). Statistical tests included Pearson correlation, Cohen’s kappa, and Bland-Altman analysis. The study included 218 post-Fontan patients (median age: 16.2 years, IQR: 12.8–22.5) and 36.2% were female. Both 4D flow methods displayed excellent interobserver reproducibility (interclass correlation > 0.95) and RFs approximately 7% lower than AVVR Report−RF . AVVR AVV−Ao (4D) showed stronger agreement with AVVR Report−RF (κ = 0.50 [95% CI: 0.25–0.75]; r = 0.49, p < 0.01). AVVR Jet demonstrated better concordance with AVVR Report−Cat (κ = 0.31 [95% CI: 0.17–0.45]). Both AVVR AVV−Ao (4D) (OR = 1.53, p = 0.004; AUC = 0.71) and AVVR Jet (OR = 1.74, p = 0.002; AUC = 0.65) were associated significantly with the composite outcome of death and heart transplantation listing. This is the first study analyzing the accuracy of 4D flow AVVR quantification in post-Fontan patients, demonstrating reproducibility, prognostic value, and good concordance with conventional methods. These findings suggest that 4D flow AVVR quantification may serve as a complementary method for assessing AVVR in post-Fontan patients.

26 May 2026 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
YLYu Li
Yu Li
MSMary Schiff
Mary Schiff
LOLaura J. Olivieri
Laura J. Olivieri
VMVivek Muthurangu
Vivek Muthurangu
TYTina Yao
Tina Yao
JWJ Weigand
J Weigand
Atrioventricular valve regurgitation (AVVR) predicts long-term post-Fontan adverse outcomes. Literature on the measurement and prognostic value of quantitative AVVR assessment using cardiac magnetic resonance imaging (CMR) is limited. This study compared echocardiographic AVVR measurements with measurements by CMR, and investigated their association with clinical outcomes using the multi-center Fontan Outcome Registry using CMR Examination (FORCE). Patients with an examiner-reported AVVR severity category from CMR (AVVRReport-Cat) and an AVVR from matched echocardiography (AVVREcho) were included. Three quantitative CMR AVVR regurgitant fraction were used: (1) stroke volume and antegrade aortic flow (AVVRStandard), (2) atrioventricular valve flow and antegrade aortic flow (AVVRAVV-AO), and (3) examiner-reported regurgitation fraction (AVVRReport-RF). Moderate AVVR was defined as regurgitant fraction of 20-40% and severe >40%. The concordance across methods was calculated using Kappa statistics, and associations with outcomes of mortality or listing for/receiving heart transplantation were analyzed using Cox proportional hazard models. C-statistic was used to compare model performance. 2,309 Fontan patients were included, with a median age at CMR of 15.7 years and 42.1% female. Categorical AVVR severity reported by CMR was significantly associated with adverse outcomes (adjusted HR 2.10, 95% CI [1.38, 3.19] for moderate and 4.61 [2.80, 7.58] for severe AVVR), comparable to AVVR reported by echocardiography. AVVRAVV-AO showed stronger concordance with AVVRReport-Cat (Kappa=0.58) and higher hazards of the adverse outcome than AVVRStandard. The subset of patients with examiner-reported regurgitation fraction (AVVRReport-RF) showed the highest hazard associated with AVVR and the highest C-statistic among all methods including echocardiography. This is the first study evaluating different CMR measurements of AVVR in a large cohort of Fontan patients. Compared with AVVRStandard, AVVRAVV-AO had higher concordance with the reported categorical AVVR using CMR. Moderate and severe AVVR determined by both CMR and echocardiography were associated with comparably increased hazards of adverse clinical outcomes.

15 July 2026 in Pediatric Cardiology
Verified
Journal Article
Open access
HLHusayn M. Ladha
Husayn M. Ladha
JWJustin C. Wang
Justin C. Wang
YLYu Li
Yu Li
ACAdam B Christopher
Adam B Christopher
JKJacqueline Kreutzer
Jacqueline Kreutzer
TATarek Alsaied
Tarek Alsaied